ZP
PHVS icon

Zimmer Partners’s Pharvaris PHVS Stock Holding History

Zimmer Partners’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,000
Closed -$420K – 212
2021
Q1 		$420K Buy
+15,000
New +$472K 0.01% 160

Other funds holding PHVS

FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Zimmer Partners's PHVS Position: Q2 2021 in Review

Zimmer Partners sold out of Pharvaris (PHVS) in Q2 2021, closing a stake of 15,000 shares — an estimated $420K sold.

Zimmer Partners first reported a position in PHVS in Q1 2021 and held it in 1 quarter. The position peaked at $420K in Q1 2021. 28 funds tracked by Wall St. Rank hold PHVS as of Q2 2021.

  • Zimmer Partners reported no remaining Pharvaris position as of Q2 2021 after selling out during the quarter.
  • Zimmer Partners sold 15,000 Pharvaris shares in Q2 2021, an estimated $420K.
  • Zimmer Partners first reported a position in Pharvaris in Q1 2021 and held it in 1 quarter.
  • Zimmer Partners's Pharvaris position peaked at $420K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Pharvaris as of Q2 2021.

Based on Zimmer Partners's 13F filing for Q2 2021, filed 16 Aug 2021.